CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $588,195
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$588,195. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-30 | Cook Robert W. Chief Financial Officer | Grant or award · Stock Option (Right to buy Common Stock) | +185,000 | 185,000 | ||
| 2017-01-30 | TELLEZ CORA M Director | Purchase | +1,780 | $1.79 | $3K | 116,531 |
| 2016-12-30 | TELLEZ CORA M Director | Purchase | +1,990 | $1.58 | $3K | 114,751 |
| 2016-12-09 | Baluch Khoso Chief Executive Officer | Purchase | +10,000 | $1.77 | $18K | 10,000 |
| 2016-11-30 | TELLEZ CORA M Director | Purchase | +1,800 | $1.80 | $3K | 112,761 |
| 2016-11-14 | GEORGE MICHAEL W Director | Purchase · Phantom Stock | +4,143 | 4,143 | ||
| 2016-11-14 | TELLEZ CORA M Director | Purchase · Common Stock | +4,143 | 4,143 | ||
| 2016-11-14 | Dillione Janet Director | Purchase · Phantom Stock | +4,143 | 4,143 | ||
| 2016-10-31 | TELLEZ CORA M Director | Purchase | +1,475 | $2.15 | $3K | 110,961 |
| 2016-10-21 | Pfaffle Antony Chief Scientific Officer | Exercise or conversion | +20,000 | $0.68 | $14K | 20,000 |
| 2016-10-21 | Pfaffle Antony Chief Scientific Officer | Sale | −20,000 | $2.23 | $45K | 0 |
| 2016-10-21 | Pfaffle Antony Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −20,000 | 80,000 | ||
| 2016-10-03 | Baluch Khoso Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,250,000 | 1,250,000 | ||
| 2016-10-03 | Baluch Khoso Chief Executive Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2016-10-03 | Baluch Khoso Chief Executive Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2016-10-03 | Baluch Khoso Chief Executive Officer | Grant or award · Stock Option (right to buy) | +1,250,000 | 1,250,000 | ||
| 2016-10-03 | Baluch Khoso Chief Executive Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2016-10-03 | Baluch Khoso Chief Executive Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2016-08-25 | Markvicka Taunia Director | Purchase | +18,600 | $1.65 | $31K | 22,600 |
| 2016-08-19 | TELLEZ CORA M Director | Purchase | +12,500 | $1.73 | $22K | 109,486 |
Page 23 of 24 · 463 trades